Big pharma companies have tried and failed. But a small start-up in Umeå may have cracked the code. Betagenon has recently initiated a phase II clinical trial aiming to prove that obesity, diabetes and cardiovascular disease can all be treated by the same drug in humans.
The number of women in leading positions Umeå Biotech Incubator’s startup companies has tripled. Interesting and promising in itself, but also with the perspective that Vinnova are looking for more women innovation talents.
Successful projects with high potential for patient benefit gives Umeå Biotech Incubator renewed confidence from the Erling-Persson Family Foundation.
2017 Biotech Umeå Investment Day is arranged on February 2nd 2017 at Grand Hotel in Stockholm. Around 80 partnering meetings are expected to be held during the event.
Lipigon Pharmaceuticals and AstraZeneca’s agreement, reported earlier this spring, has potential to be one of the largest deals for any life sciences SME company in Sweden. We caught Lars Öhman, chairman of Lipigon, at BIO in San Francisco to learn more on how they did it and what to expect in the future.
Fredrik Almqvist, professor in organic chemistry at Umeå University and serial entrepreneur, receives Baltic’s collaboration and entrepreneurship award. He receives the award for successfully combining entrepreneurship with excellent research in chemical production and the combat against pathogenic bacteria.
Umecrine Cognition has raised new funds to support clinical development of novel drug candidate GR3027 for hepatic encephalopathy – Phase I clinical trial initiated.
LunaLEC from Umeå is ranked as one of the ten most promising clean tech startups in the Nordic countries.
QureTech Bio AB, a start-up from Umeå, developing first line drugs to combat antibiotic resistance and infectious diseases, won the BIO-Europe Spring Start-up Slam, in competition with 16 other presentations from 16 other Swedish life sciences start-up companies.
On April 5th, Sweden’s ten most innovative entrepreneurs in were bestowed with awards. MYoroface, a company connected to Uminova Innovation and Biotech Umeå, were one of the companies to receive a 200 000 SEK stipend. Swedish Incubators & Science Parks (SISP) and the Åforsk foundation appointed the winners and presented the stipends to the laureates at Sveriges Innovationsriksdag in Åre.
Brain Stimulation AB is a start-up company in e-health from Umeå. The company has developed a unique treatment method that both diagnoses and rehabilitates stroke patients who suffer from one-side neglect. The company is supported by an investment from Almi Invest. The product, RehAtt™, provides brain stimulation in a fun 3D game. The game combines neuroscience, virtual reality (VR) and robotics to help more patients return to a more normal daily life.
Medica Trade Fair, November 14-17, Düsseldorf, Germany
Bubbel & Debatt - Tema: Sverige satsar nationellt på life science. Vad görs i Din Region?
Biotech Umeå Investment Day 2017
Biotech Umeå, Uminova Innovation
Box 7978, SE-907 19 Umeå